This study exists to see whether psychoeducation, a guided learning and support program, is workable and worth testing more broadly. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can give earlier or clearer feedback during care.

In United States

BipolarityBehavioralFrom 7 Years to 14 Years

Countries: United States
Sponsor: L. Eugene Arnold
Condition: Bipolarity

View study

CompletedNCT01786239

Omega-3 Dietary Supplements in Schizophrenia

This study exists to compare options and see whether questionnaires and follow-up reports offers something meaningfully different. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

In United States

Schizophrenia, BipolarityDrugFrom 15 Years to 40 Years

Countries: United States
Sponsor: Delbert Robinson
Condition: Schizophrenia, Bipolarity

View study

TerminatedNCT00592683

Omega-3 Fatty Acid Adjunctive to Aripiprazole for Bipolarity in Children and Adolescents

This study was terminated in the United States. It focuses on Bipolarity.

In United States

BipolarityDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Bipolarity

View study

CompletedNCT00585390

Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 8 Years to 25 Years

Countries: United States
Sponsor: University of Cincinnati
Condition: Schizophrenia

View study

CompletedNCT01399827

Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: ADHD

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.